The congenital nephrotic syndrome.
D001201:Ascites / Q000209:etiology; D003520:Cyclophosphamide / Q000627:therapeutic use; D004487:Edema / Q000209:etiology; D005260:Female; D006801:Humans; D006984:Hypertrophy; D007019:Hypoproteinemia / Q000209:etiology; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007231:Infant, Newborn; D007668:Kidney / Q000473:pathology; D008297:Male; D009404:Nephrotic Syndrome / Q000145:classification / Q000150:complications / Q000151:congenital* / Q000188:drug therapy / Q000235:genetics / Q000276:immunology / Q000473:pathology; D011507:Proteinuria / Q000209:etiology
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D003520:Cyclophosphamide